Where does Ventana Medical Systems, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ventana Medical Systems, Inc. ranks #1,140 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ventana Medical Systems, Inc. hold?

Ventana Medical Systems, Inc. holds 371 US utility patents granted between 2015 and 2025, spanning 47 technology areas.

What is Ventana Medical Systems, Inc.'s Innovation Score?

Ventana Medical Systems, Inc. has an Innovation Score of 61.8 out of 100 (top 3% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Ventana Medical Systems, Inc. focus on?

Ventana Medical Systems, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 224 patents, ranking #49 of 7,863 assignees active in that subclass. Grants appear in 47 CPC subclasses total.

Is Ventana Medical Systems, Inc.'s patent grant rate increasing or decreasing?

Ventana Medical Systems, Inc.'s recent grant velocity is +146% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Ventana Medical Systems, Inc.'s patents?

Ventana Medical Systems, Inc.'s patents average 18.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ventana Medical Systems, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Ventana Medical Systems, Inc.

USPTO PatentsView assignee record - 371 granted patents across 47 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ventana ranks #1,140 of 49,997 tracked US assignees by granted-patent volume, with 371 patents across 47 technology areas.

#1,140
of 49,997 US assignees by volume: Top 3%
by Innovation Score (61.8/100): 18.1
avg claims per patent: +146%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1140 · US Corporation #1,140 · 371 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 371 grants
TOP-DECILE #1,140/49,997
PHOTO-FINISH HL Mando
CPC-WIDE G01N · 47 areas
INNOV-STRONG 61.8/100
CLAIMS-RICH 18.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +146% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: HL Mando Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ventana’s 61.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 20.4 pts (33%) Velocity 6.3 pts (10%) Breadth 24.2 pts (39%) Claim depth 10.8 pts (18%)

Qualcomm Incorporated · highest

85
Ebara · near

62
Shenzhen Institutes… · near

62
Ventana Medical… · this assignee

62
Walgreen · near

62
Marvell International · near

62
3D Lighting… · lowest

7

What this shows Ventana's Innovation Score is 61.8/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ventana?

Each dot is one of Ventana’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ventana’s own 18.1 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ventana vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ventana's grants concentrate

Ventana Medical Systems, Inc. is a focused PatentsView assignee: 47 CPC subclasses with 60.4% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2021 (54 grants) versus a trough of 12 in 2015. By volume, Ventana sits between Samsung SDS Co., Ltd. and Ivoclar Vivadent AG.

Ventana's three-year grant acceleration

From 2019–2021 to 2022–2024, Ventana Medical Systems, Inc. moved from 140 to 132 grants (0.94x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,351. See the growth leaderboard.

Samsung SDS

372
HL Mando

371
Puma SE

371
The Curators of t…

371
Ventana Medical S… ◀

371
Ball Horticultural

370
Dentsply Sirona

370
Eagle Industry

370
Ivoclar Vivadent

370

What this shows Ventana holds 371 patents at rank #1,140, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ventana

By rank, the assignees closest to #1,140 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Ventana's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ventana, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Ventana ranks #49 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (62 here).

Walgreen Co. 62 Ebara Corporation 62 Shenzhen Institutes OF Advanced Technology 62 Marvell International Ltd. 62

Similar claim depth

Nearest assignees by average claims per patent (18.1 here).

Ocado Innovation Limited 18.1 avg Institut National D'optique 18.1 avg SuccessFactors, Inc. 18.1 avg Innospec Limited 18.1 avg

Ventana's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Ventana Medical Systems, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	12	3.2%
2016	15	4.0%
2017	13	3.5%
2018	20	5.4%
2019	36	9.7%
2020	50	13.5%
2021	54	14.6%
2022	30	8.1%
2023	50	13.5%
2024	52	14.0%
2025partial year	39	10.5%

Which technologies does Ventana Medical Systems, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 224

G06T - Image Data Processing OR Generation, IN General 121

G06V - Image OR Video Recognition OR Understanding 103

G02B - Optical Elements, Systems OR Apparatus 59

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 50

G06F - Electric Digital Data Processing 47

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 42

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 33

C07K - Peptides 31

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 21

H04N - Pictorial Communication, e.g. Television 17

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 15

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 13

Y10T - Technical Subjects Covered BY Former US Classification 13

G06N - Computing Arrangements Based ON Specific Computational Models 9

Top 15 of 47 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ventana Medical Systems, Inc.'s patent record in context - here's where to go next.

Ventana Medical Systems, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 60.4% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #1,140 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ventana Medical Systems, Inc. against Samsung SDS Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 61.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.